iCE Neurosystems

iCE Neurosystems is a private, commercial-stage medical device company founded in 2016 and based in Cambridge, USA. The company has developed the FDA-cleared iCEWav platform, which combines single-use subcutaneous electrodes, a bedside monitor, and a cloud analytics layer to deliver continuous, integrated brain function data alongside traditional vital signs. Its mission is to transform electroencephalography (EEG) into a scalable, clinician-friendly vital sign for the brain to detect and prevent irreversible brain injury in millions of critically ill patients. The company is positioned in the high-growth neurocritical care monitoring market, targeting a significant gap in standard ICU protocols.

The iCEWav Platform: an integrated ecosystem of proprietary subcutaneous EEG electrodes, a bedside multimodal data acquisition/visualization system, and a cloud-based analytics layer designed to deliver continuous, structured brain vital sign data.

Competition includes large medical device companies (e.g., Natus, Nihon Kohden) offering traditional EEG systems, and startups developing simplified brain monitors. iCE Neuro's differentiation is its fully integrated platform combining easy-to-apply electrodes, multimodal data integration, and cloud analytics designed specifically for scalability in the ICU.